Average number of colonies in healthy controls and in CML patients and reduction in the colony-forming ability of healthy and CML myeloid progenitors after treatment with IM, LMB, or their combination
. | No treatment . | IM . | LMB . | IM + LMB . |
|---|---|---|---|---|
| Healthy controls | ||||
| Colonies, no. | 105 | 73 | 44 | 51 |
| Reduction, % (95% CI) | — | 40 (29-49) | 61 (53-68) | 59 (41-72) |
| Patients with CML | ||||
| Colonies, no. | 91 | 62 | 21 | 13 |
| Reduction, % (95% CI) | — | 37 (33-40) | 79 (78-81) | 88 (82-92) |
. | No treatment . | IM . | LMB . | IM + LMB . |
|---|---|---|---|---|
| Healthy controls | ||||
| Colonies, no. | 105 | 73 | 44 | 51 |
| Reduction, % (95% CI) | — | 40 (29-49) | 61 (53-68) | 59 (41-72) |
| Patients with CML | ||||
| Colonies, no. | 91 | 62 | 21 | 13 |
| Reduction, % (95% CI) | — | 37 (33-40) | 79 (78-81) | 88 (82-92) |
— indicates not applicable.